Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. cuba. invest. bioméd ; 40(4)dic. 2021. ilus
Artigo em Espanhol | LILACS, CUMED | ID: biblio-1408599

RESUMO

Introducción: Mycoplasma pneumoniae es una bacteria de distribución mundial que comúnmente ocasiona infecciones respiratorias en forma de traqueobronquitis y neumonía atípica, recientemente se ha descrito como etiología de una enfermedad denominada Mycoplasma-induced rash and mucositis. Caso clínico: Varón de 11 años, procedente del departamento de Tacna en Perú que se presentó con cuatro días de enfermedad caracterizado por fiebre, tos, disnea, conjuntivitis bilateral purulenta y lesiones erosivas muy dolorosas en mucosa yugal, lengua y labios, recibió tratamiento antibiótico, antiviral y antifúngico, evolucionando favorablemente. Se confirmó infección por Mycoplasma pneumoniae mediante serología IgM por ELISA. De nuestro conocimiento, este es el primer caso de Mucositis sin rash inducido por Mycoplasma pneumoniae reportado en Perú, el reconocimiento temprano de este síndrome permitirá un tratamiento más específico, evitando la restricción de fármacos apropiados(AU)


Introduction: Mycoplasma pneumoniae is a bacterium of worldwide distribution which commonly causes respiratory infections such as tracheobronchitis and atypical pneumonia. It has recently been described as etiology of a disease called Mycoplasma pneumoniae-induced rash and mucositis. Objective: Present the first known report of Mycoplasma pneumoniae-associated mucositis in Peru, diagnosed by compatible clinical picture and confirmed by serology. Clinical case: A male 11-year-old patient from the Tacna Region in Peru presented with a clinical state of four days' evolution characterized by fever, coughing, dyspnea, bilateral purulent conjunctivitis and very painful erosive lesions on the jugal mucosa, tongue and lips. The patient received antibiotic, antiviral and antifungal treatment, to which he responded favorably. Mycoplasma pneumoniae infection was confirmed by IgM ELISA serology. Conclusions: Early recognition of this syndrome will lead to a more specific treatment, avoiding the restriction of appropriate drugs(AU)


Assuntos
Humanos , Masculino , Criança , Pneumonia por Mycoplasma/etiologia , Mucosite/diagnóstico , Conjuntivite Bacteriana/complicações , Mucosa Bucal/lesões
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA